Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease-Reference-Cited by-同舟云学术

Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease

Published:2020-02-01 Issue:2 Volume:77 Page:164
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Howard Robert¹,Zubko Olga²,Bradley Rosie³,Harper Emma⁴,Pank Lynn⁴,O’Brien John⁵,Fox Chris⁶,Tabet Naji⁷,Livingston Gill¹,Bentham Peter⁸,McShane Rupert⁹,Burns Alistair¹⁰,Ritchie Craig¹¹,Reeves Suzanne¹,Lovestone Simon⁹,Ballard Clive¹²,Noble Wendy¹³,Nilforooshan Ramin¹⁴,Wilcock Gordon¹⁵,Gray Richard⁴,

Affiliation:

1. Division of Psychiatry, University College London, London, United Kingdom

2. Old Age Psychiatry, King’s College London, London, United Kingdom

3. Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom

4. Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

5. Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom

6. Norwich Medical School, University of East Anglia, Norwich, United Kingdom

7. Department of Old Age Psychiatry, University of Sussex, Brighton, United Kingdom

8. Birmingham and Solihull Mental Health National Health Service Foundation Trust, Birmingham, United Kingdom

9. Department of Psychiatry, University of Oxford, Oxford, United Kingdom

10. Department of Old Age Psychiatry, University of Manchester, Manchester, United Kingdom

11. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom

12. Medical School, University of Exeter, Exeter, United Kingdom

13. Department of Basic and Clinical Neuroscience, King’s College London, London, United Kingdom

14. Surrey and Borders Partnership National Health Service Foundation Trust, United Kingdom

15. Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2755279/jamaneurology_howard_2019_oi_190089.pdf

Reference31 articles.

1. A pivotal moment in Alzheimer’s disease and dementia: how global unity of purpose and action can beat the disease by 2025.;Vradenburg;Expert Rev Neurother,2015

2. Alzheimer’s disease risk genes and mechanisms of disease pathogenesis.;Karch;Biol Psychiatry,2015

3. In vivo imaging of glial activation in Alzheimer’s disease.;Edison;Front Neurol,2018

4. Alzheimer’s disease: innate immunity gone awry?;VanItallie;Metabolism,2017

5. Microglial Aß receptors in Alzheimer’s disease.;Yu;Cell Mol Neurobiol,2015

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of plant-derived natural compounds in Alzheimer’s disease: Targeting microglia-mediated neuroinflammation;Biomedicine & Pharmacotherapy;2024-09

2. Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis;International Immunopharmacology;2024-09

3. Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial;Breast Cancer Research and Treatment;2024-08-14

4. Turning microglia neuroprotective: Towards connexin43-specific therapy of Alzheimer’s disease;2024-08-08

5. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission;The Lancet;2024-08